Skip to content
中文产业新闻精选评分70Chinese source

同源康医药TY-9591获NMPA批准,一线治疗EGFR突变伴脑转移NSCLC

一线治疗肺癌脑转移!同源康医药创新 EGFR-TKI 重磅获批

No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.